JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2152407, encodeId=a94d215240ee6, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：请问大家可以看到分配的编辑吗，我这显示Submission under peer review21 Jul 2023，然后显示 5 Reviewer(s) invited 26 Jul 23。首页上又说再找编辑。We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks. 这是说我还没有编辑的意思吗，是不是没有编辑也没有人继续邀请审稿人啊，我能发邮件催吗，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b6c6396308, createdName=ms4000001131300035, createdTime=Sat Aug 12 10:52:29 CST 2023, time=2023-08-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151540, encodeId=f809215154037, content=请问大家，只有一个审稿人接收并提了意见，编辑会继续等第二个审稿人吗，时间也很长了，还是一个审稿人也可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/CCHXoTpZnFFfvva1H3xy1aeibn3UIslJAJQyZB1EA2ITXuG1sPcI48iaFvo5M8huD9dXqfLx0HUrExRmqm93YiaNQ/132, createdBy=a6f15243638, createdName=小伊森7290, createdTime=Sun Aug 06 22:51:12 CST 2023, time=2023-08-06, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2152409, encodeId=39a321524096f, content=这个期刊如果送外审后接收概率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221101/b9adfc4dea984dda8e0e6610a2452d0b/ac3111247cf04c10ab769ff52aeea3ca.jpg, createdBy=fb758187561, createdName=muei, createdTime=Sat Aug 12 10:53:14 CST 2023, time=2023-08-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151634, encodeId=24512151634d1, content=偏重的研究方向：肿瘤标志物;肝癌 经验分享：系统显示Peer review，怎么查看有几个审稿人呢，是不是还没审稿人愿意审稿？因为系统上还显示Your submission has passed the technical checks and is now in peer review We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Mon Aug 07 16:29:20 CST 2023, time=2023-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151745, encodeId=a6aa2151e45c6, content=APC费用：£2690.00/$4190.00/€3190.00, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcd85631555, createdName=医学空, createdTime=Tue Aug 08 10:53:37 CST 2023, time=2023-08-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2151711, encodeId=55fc2151e11b0, content=请问大家润色怎么处理的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Tue Aug 08 00:53:43 CST 2023, time=2023-08-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2142239, encodeId=d3b0214223935, content=偏重的研究方向：肿瘤临床;肝癌 经验分享：兄弟姐妹们咨询一下这个杂志选择传统订阅和OA 见刊的时间有什么区别啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Jun 11 18:35:54 CST 2023, time=2023-06-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2148975, encodeId=54d021489e5d8, content=快一个月了，还在审稿中，毕业需要，急死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201213/0c5ac7effe254ae4bce0fa2cc2887867/6649319072f04f49b9aaca73a211cec5.jpg, createdBy=9aac2516251, createdName=小懒emma, createdTime=Thu Jul 20 12:01:34 CST 2023, time=2023-07-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2151132, encodeId=0a4e215113204, content=请问这个杂志给了修改后辈=被拒的可能性大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=112d5638756, createdName=ms1000001834918815, createdTime=Thu Aug 03 17:18:20 CST 2023, time=2023-08-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2143995, encodeId=67b8214399524, content=投稿的大神吗，求求参考文献的格式呀？不知道什么名字呀，endnote里不知道该选谁, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c7a8160924, createdName=ms5000001590163843, createdTime=Tue Jun 20 23:46:57 CST 2023, time=2023-06-20, status=1, ipAttribution=辽宁省)]

2023-08-12 ms4000001131300035 来自四川省

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：肿瘤
经验分享：请问大家可以看到分配的编辑吗，我这显示Submission under peer review21 Jul 2023，然后显示
5 Reviewer(s) invited 26 Jul 23。首页上又说再找编辑。We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks.
这是说我还没有编辑的意思吗，是不是没有编辑也没有人继续邀请审稿人啊，我能发邮件催吗，着急

21 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2152407, encodeId=a94d215240ee6, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：请问大家可以看到分配的编辑吗，我这显示Submission under peer review21 Jul 2023，然后显示 5 Reviewer(s) invited 26 Jul 23。首页上又说再找编辑。We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks. 这是说我还没有编辑的意思吗，是不是没有编辑也没有人继续邀请审稿人啊，我能发邮件催吗，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b6c6396308, createdName=ms4000001131300035, createdTime=Sat Aug 12 10:52:29 CST 2023, time=2023-08-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151540, encodeId=f809215154037, content=请问大家，只有一个审稿人接收并提了意见，编辑会继续等第二个审稿人吗，时间也很长了，还是一个审稿人也可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/CCHXoTpZnFFfvva1H3xy1aeibn3UIslJAJQyZB1EA2ITXuG1sPcI48iaFvo5M8huD9dXqfLx0HUrExRmqm93YiaNQ/132, createdBy=a6f15243638, createdName=小伊森7290, createdTime=Sun Aug 06 22:51:12 CST 2023, time=2023-08-06, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2152409, encodeId=39a321524096f, content=这个期刊如果送外审后接收概率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221101/b9adfc4dea984dda8e0e6610a2452d0b/ac3111247cf04c10ab769ff52aeea3ca.jpg, createdBy=fb758187561, createdName=muei, createdTime=Sat Aug 12 10:53:14 CST 2023, time=2023-08-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151634, encodeId=24512151634d1, content=偏重的研究方向：肿瘤标志物;肝癌 经验分享：系统显示Peer review，怎么查看有几个审稿人呢，是不是还没审稿人愿意审稿？因为系统上还显示Your submission has passed the technical checks and is now in peer review We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Mon Aug 07 16:29:20 CST 2023, time=2023-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151745, encodeId=a6aa2151e45c6, content=APC费用：£2690.00/$4190.00/€3190.00, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcd85631555, createdName=医学空, createdTime=Tue Aug 08 10:53:37 CST 2023, time=2023-08-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2151711, encodeId=55fc2151e11b0, content=请问大家润色怎么处理的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Tue Aug 08 00:53:43 CST 2023, time=2023-08-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2142239, encodeId=d3b0214223935, content=偏重的研究方向：肿瘤临床;肝癌 经验分享：兄弟姐妹们咨询一下这个杂志选择传统订阅和OA 见刊的时间有什么区别啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Jun 11 18:35:54 CST 2023, time=2023-06-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2148975, encodeId=54d021489e5d8, content=快一个月了，还在审稿中，毕业需要，急死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201213/0c5ac7effe254ae4bce0fa2cc2887867/6649319072f04f49b9aaca73a211cec5.jpg, createdBy=9aac2516251, createdName=小懒emma, createdTime=Thu Jul 20 12:01:34 CST 2023, time=2023-07-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2151132, encodeId=0a4e215113204, content=请问这个杂志给了修改后辈=被拒的可能性大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=112d5638756, createdName=ms1000001834918815, createdTime=Thu Aug 03 17:18:20 CST 2023, time=2023-08-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2143995, encodeId=67b8214399524, content=投稿的大神吗，求求参考文献的格式呀？不知道什么名字呀，endnote里不知道该选谁, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c7a8160924, createdName=ms5000001590163843, createdTime=Tue Jun 20 23:46:57 CST 2023, time=2023-06-20, status=1, ipAttribution=辽宁省)]

2023-08-06 小伊森7290 来自天津

请问大家，只有一个审稿人接收并提了意见，编辑会继续等第二个审稿人吗，时间也很长了，还是一个审稿人也可以

25 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2152407, encodeId=a94d215240ee6, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：请问大家可以看到分配的编辑吗，我这显示Submission under peer review21 Jul 2023，然后显示 5 Reviewer(s) invited 26 Jul 23。首页上又说再找编辑。We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks. 这是说我还没有编辑的意思吗，是不是没有编辑也没有人继续邀请审稿人啊，我能发邮件催吗，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b6c6396308, createdName=ms4000001131300035, createdTime=Sat Aug 12 10:52:29 CST 2023, time=2023-08-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151540, encodeId=f809215154037, content=请问大家，只有一个审稿人接收并提了意见，编辑会继续等第二个审稿人吗，时间也很长了，还是一个审稿人也可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/CCHXoTpZnFFfvva1H3xy1aeibn3UIslJAJQyZB1EA2ITXuG1sPcI48iaFvo5M8huD9dXqfLx0HUrExRmqm93YiaNQ/132, createdBy=a6f15243638, createdName=小伊森7290, createdTime=Sun Aug 06 22:51:12 CST 2023, time=2023-08-06, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2152409, encodeId=39a321524096f, content=这个期刊如果送外审后接收概率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221101/b9adfc4dea984dda8e0e6610a2452d0b/ac3111247cf04c10ab769ff52aeea3ca.jpg, createdBy=fb758187561, createdName=muei, createdTime=Sat Aug 12 10:53:14 CST 2023, time=2023-08-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151634, encodeId=24512151634d1, content=偏重的研究方向：肿瘤标志物;肝癌 经验分享：系统显示Peer review，怎么查看有几个审稿人呢，是不是还没审稿人愿意审稿？因为系统上还显示Your submission has passed the technical checks and is now in peer review We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Mon Aug 07 16:29:20 CST 2023, time=2023-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151745, encodeId=a6aa2151e45c6, content=APC费用：£2690.00/$4190.00/€3190.00, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcd85631555, createdName=医学空, createdTime=Tue Aug 08 10:53:37 CST 2023, time=2023-08-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2151711, encodeId=55fc2151e11b0, content=请问大家润色怎么处理的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Tue Aug 08 00:53:43 CST 2023, time=2023-08-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2142239, encodeId=d3b0214223935, content=偏重的研究方向：肿瘤临床;肝癌 经验分享：兄弟姐妹们咨询一下这个杂志选择传统订阅和OA 见刊的时间有什么区别啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Jun 11 18:35:54 CST 2023, time=2023-06-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2148975, encodeId=54d021489e5d8, content=快一个月了，还在审稿中，毕业需要，急死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201213/0c5ac7effe254ae4bce0fa2cc2887867/6649319072f04f49b9aaca73a211cec5.jpg, createdBy=9aac2516251, createdName=小懒emma, createdTime=Thu Jul 20 12:01:34 CST 2023, time=2023-07-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2151132, encodeId=0a4e215113204, content=请问这个杂志给了修改后辈=被拒的可能性大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=112d5638756, createdName=ms1000001834918815, createdTime=Thu Aug 03 17:18:20 CST 2023, time=2023-08-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2143995, encodeId=67b8214399524, content=投稿的大神吗，求求参考文献的格式呀？不知道什么名字呀，endnote里不知道该选谁, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c7a8160924, createdName=ms5000001590163843, createdTime=Tue Jun 20 23:46:57 CST 2023, time=2023-06-20, status=1, ipAttribution=辽宁省)]

2023-08-12 muei 来自四川省

这个期刊如果送外审后接收概率大吗

89 0

[GetPortalCommentsPageByObjectIdResponse(id=2152407, encodeId=a94d215240ee6, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：请问大家可以看到分配的编辑吗，我这显示Submission under peer review21 Jul 2023，然后显示 5 Reviewer(s) invited 26 Jul 23。首页上又说再找编辑。We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks. 这是说我还没有编辑的意思吗，是不是没有编辑也没有人继续邀请审稿人啊，我能发邮件催吗，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b6c6396308, createdName=ms4000001131300035, createdTime=Sat Aug 12 10:52:29 CST 2023, time=2023-08-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151540, encodeId=f809215154037, content=请问大家，只有一个审稿人接收并提了意见，编辑会继续等第二个审稿人吗，时间也很长了，还是一个审稿人也可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/CCHXoTpZnFFfvva1H3xy1aeibn3UIslJAJQyZB1EA2ITXuG1sPcI48iaFvo5M8huD9dXqfLx0HUrExRmqm93YiaNQ/132, createdBy=a6f15243638, createdName=小伊森7290, createdTime=Sun Aug 06 22:51:12 CST 2023, time=2023-08-06, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2152409, encodeId=39a321524096f, content=这个期刊如果送外审后接收概率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221101/b9adfc4dea984dda8e0e6610a2452d0b/ac3111247cf04c10ab769ff52aeea3ca.jpg, createdBy=fb758187561, createdName=muei, createdTime=Sat Aug 12 10:53:14 CST 2023, time=2023-08-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151634, encodeId=24512151634d1, content=偏重的研究方向：肿瘤标志物;肝癌 经验分享：系统显示Peer review，怎么查看有几个审稿人呢，是不是还没审稿人愿意审稿？因为系统上还显示Your submission has passed the technical checks and is now in peer review We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Mon Aug 07 16:29:20 CST 2023, time=2023-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151745, encodeId=a6aa2151e45c6, content=APC费用：£2690.00/$4190.00/€3190.00, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcd85631555, createdName=医学空, createdTime=Tue Aug 08 10:53:37 CST 2023, time=2023-08-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2151711, encodeId=55fc2151e11b0, content=请问大家润色怎么处理的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Tue Aug 08 00:53:43 CST 2023, time=2023-08-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2142239, encodeId=d3b0214223935, content=偏重的研究方向：肿瘤临床;肝癌 经验分享：兄弟姐妹们咨询一下这个杂志选择传统订阅和OA 见刊的时间有什么区别啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Jun 11 18:35:54 CST 2023, time=2023-06-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2148975, encodeId=54d021489e5d8, content=快一个月了，还在审稿中，毕业需要，急死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201213/0c5ac7effe254ae4bce0fa2cc2887867/6649319072f04f49b9aaca73a211cec5.jpg, createdBy=9aac2516251, createdName=小懒emma, createdTime=Thu Jul 20 12:01:34 CST 2023, time=2023-07-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2151132, encodeId=0a4e215113204, content=请问这个杂志给了修改后辈=被拒的可能性大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=112d5638756, createdName=ms1000001834918815, createdTime=Thu Aug 03 17:18:20 CST 2023, time=2023-08-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2143995, encodeId=67b8214399524, content=投稿的大神吗，求求参考文献的格式呀？不知道什么名字呀，endnote里不知道该选谁, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c7a8160924, createdName=ms5000001590163843, createdTime=Tue Jun 20 23:46:57 CST 2023, time=2023-06-20, status=1, ipAttribution=辽宁省)]

2023-08-07 ms4000001156703951

偏重的研究方向：肿瘤标志物;肝癌
经验分享：系统显示Peer review，怎么查看有几个审稿人呢，是不是还没审稿人愿意审稿？因为系统上还显示Your submission has passed the technical checks and is now in peer review
We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks.

24 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2152407, encodeId=a94d215240ee6, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：请问大家可以看到分配的编辑吗，我这显示Submission under peer review21 Jul 2023，然后显示 5 Reviewer(s) invited 26 Jul 23。首页上又说再找编辑。We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks. 这是说我还没有编辑的意思吗，是不是没有编辑也没有人继续邀请审稿人啊，我能发邮件催吗，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b6c6396308, createdName=ms4000001131300035, createdTime=Sat Aug 12 10:52:29 CST 2023, time=2023-08-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151540, encodeId=f809215154037, content=请问大家，只有一个审稿人接收并提了意见，编辑会继续等第二个审稿人吗，时间也很长了，还是一个审稿人也可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/CCHXoTpZnFFfvva1H3xy1aeibn3UIslJAJQyZB1EA2ITXuG1sPcI48iaFvo5M8huD9dXqfLx0HUrExRmqm93YiaNQ/132, createdBy=a6f15243638, createdName=小伊森7290, createdTime=Sun Aug 06 22:51:12 CST 2023, time=2023-08-06, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2152409, encodeId=39a321524096f, content=这个期刊如果送外审后接收概率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221101/b9adfc4dea984dda8e0e6610a2452d0b/ac3111247cf04c10ab769ff52aeea3ca.jpg, createdBy=fb758187561, createdName=muei, createdTime=Sat Aug 12 10:53:14 CST 2023, time=2023-08-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151634, encodeId=24512151634d1, content=偏重的研究方向：肿瘤标志物;肝癌 经验分享：系统显示Peer review，怎么查看有几个审稿人呢，是不是还没审稿人愿意审稿？因为系统上还显示Your submission has passed the technical checks and is now in peer review We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Mon Aug 07 16:29:20 CST 2023, time=2023-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151745, encodeId=a6aa2151e45c6, content=APC费用：£2690.00/$4190.00/€3190.00, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcd85631555, createdName=医学空, createdTime=Tue Aug 08 10:53:37 CST 2023, time=2023-08-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2151711, encodeId=55fc2151e11b0, content=请问大家润色怎么处理的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Tue Aug 08 00:53:43 CST 2023, time=2023-08-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2142239, encodeId=d3b0214223935, content=偏重的研究方向：肿瘤临床;肝癌 经验分享：兄弟姐妹们咨询一下这个杂志选择传统订阅和OA 见刊的时间有什么区别啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Jun 11 18:35:54 CST 2023, time=2023-06-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2148975, encodeId=54d021489e5d8, content=快一个月了，还在审稿中，毕业需要，急死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201213/0c5ac7effe254ae4bce0fa2cc2887867/6649319072f04f49b9aaca73a211cec5.jpg, createdBy=9aac2516251, createdName=小懒emma, createdTime=Thu Jul 20 12:01:34 CST 2023, time=2023-07-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2151132, encodeId=0a4e215113204, content=请问这个杂志给了修改后辈=被拒的可能性大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=112d5638756, createdName=ms1000001834918815, createdTime=Thu Aug 03 17:18:20 CST 2023, time=2023-08-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2143995, encodeId=67b8214399524, content=投稿的大神吗，求求参考文献的格式呀？不知道什么名字呀，endnote里不知道该选谁, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c7a8160924, createdName=ms5000001590163843, createdTime=Tue Jun 20 23:46:57 CST 2023, time=2023-06-20, status=1, ipAttribution=辽宁省)]

2023-08-08 医学空来自上海

APC费用：£2690.00/$4190.00/€3190.00

15 0

[GetPortalCommentsPageByObjectIdResponse(id=2152407, encodeId=a94d215240ee6, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：请问大家可以看到分配的编辑吗，我这显示Submission under peer review21 Jul 2023，然后显示 5 Reviewer(s) invited 26 Jul 23。首页上又说再找编辑。We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks. 这是说我还没有编辑的意思吗，是不是没有编辑也没有人继续邀请审稿人啊，我能发邮件催吗，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b6c6396308, createdName=ms4000001131300035, createdTime=Sat Aug 12 10:52:29 CST 2023, time=2023-08-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151540, encodeId=f809215154037, content=请问大家，只有一个审稿人接收并提了意见，编辑会继续等第二个审稿人吗，时间也很长了，还是一个审稿人也可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/CCHXoTpZnFFfvva1H3xy1aeibn3UIslJAJQyZB1EA2ITXuG1sPcI48iaFvo5M8huD9dXqfLx0HUrExRmqm93YiaNQ/132, createdBy=a6f15243638, createdName=小伊森7290, createdTime=Sun Aug 06 22:51:12 CST 2023, time=2023-08-06, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2152409, encodeId=39a321524096f, content=这个期刊如果送外审后接收概率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221101/b9adfc4dea984dda8e0e6610a2452d0b/ac3111247cf04c10ab769ff52aeea3ca.jpg, createdBy=fb758187561, createdName=muei, createdTime=Sat Aug 12 10:53:14 CST 2023, time=2023-08-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151634, encodeId=24512151634d1, content=偏重的研究方向：肿瘤标志物;肝癌 经验分享：系统显示Peer review，怎么查看有几个审稿人呢，是不是还没审稿人愿意审稿？因为系统上还显示Your submission has passed the technical checks and is now in peer review We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Mon Aug 07 16:29:20 CST 2023, time=2023-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151745, encodeId=a6aa2151e45c6, content=APC费用：£2690.00/$4190.00/€3190.00, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcd85631555, createdName=医学空, createdTime=Tue Aug 08 10:53:37 CST 2023, time=2023-08-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2151711, encodeId=55fc2151e11b0, content=请问大家润色怎么处理的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Tue Aug 08 00:53:43 CST 2023, time=2023-08-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2142239, encodeId=d3b0214223935, content=偏重的研究方向：肿瘤临床;肝癌 经验分享：兄弟姐妹们咨询一下这个杂志选择传统订阅和OA 见刊的时间有什么区别啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Jun 11 18:35:54 CST 2023, time=2023-06-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2148975, encodeId=54d021489e5d8, content=快一个月了，还在审稿中，毕业需要，急死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201213/0c5ac7effe254ae4bce0fa2cc2887867/6649319072f04f49b9aaca73a211cec5.jpg, createdBy=9aac2516251, createdName=小懒emma, createdTime=Thu Jul 20 12:01:34 CST 2023, time=2023-07-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2151132, encodeId=0a4e215113204, content=请问这个杂志给了修改后辈=被拒的可能性大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=112d5638756, createdName=ms1000001834918815, createdTime=Thu Aug 03 17:18:20 CST 2023, time=2023-08-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2143995, encodeId=67b8214399524, content=投稿的大神吗，求求参考文献的格式呀？不知道什么名字呀，endnote里不知道该选谁, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c7a8160924, createdName=ms5000001590163843, createdTime=Tue Jun 20 23:46:57 CST 2023, time=2023-06-20, status=1, ipAttribution=辽宁省)]

2023-08-08 肿瘤-Doctor Zhu 来自浙江省

请问大家润色怎么处理的啊

13 0

[GetPortalCommentsPageByObjectIdResponse(id=2152407, encodeId=a94d215240ee6, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：请问大家可以看到分配的编辑吗，我这显示Submission under peer review21 Jul 2023，然后显示 5 Reviewer(s) invited 26 Jul 23。首页上又说再找编辑。We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks. 这是说我还没有编辑的意思吗，是不是没有编辑也没有人继续邀请审稿人啊，我能发邮件催吗，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b6c6396308, createdName=ms4000001131300035, createdTime=Sat Aug 12 10:52:29 CST 2023, time=2023-08-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151540, encodeId=f809215154037, content=请问大家，只有一个审稿人接收并提了意见，编辑会继续等第二个审稿人吗，时间也很长了，还是一个审稿人也可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/CCHXoTpZnFFfvva1H3xy1aeibn3UIslJAJQyZB1EA2ITXuG1sPcI48iaFvo5M8huD9dXqfLx0HUrExRmqm93YiaNQ/132, createdBy=a6f15243638, createdName=小伊森7290, createdTime=Sun Aug 06 22:51:12 CST 2023, time=2023-08-06, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2152409, encodeId=39a321524096f, content=这个期刊如果送外审后接收概率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221101/b9adfc4dea984dda8e0e6610a2452d0b/ac3111247cf04c10ab769ff52aeea3ca.jpg, createdBy=fb758187561, createdName=muei, createdTime=Sat Aug 12 10:53:14 CST 2023, time=2023-08-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151634, encodeId=24512151634d1, content=偏重的研究方向：肿瘤标志物;肝癌 经验分享：系统显示Peer review，怎么查看有几个审稿人呢，是不是还没审稿人愿意审稿？因为系统上还显示Your submission has passed the technical checks and is now in peer review We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Mon Aug 07 16:29:20 CST 2023, time=2023-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151745, encodeId=a6aa2151e45c6, content=APC费用：£2690.00/$4190.00/€3190.00, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcd85631555, createdName=医学空, createdTime=Tue Aug 08 10:53:37 CST 2023, time=2023-08-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2151711, encodeId=55fc2151e11b0, content=请问大家润色怎么处理的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Tue Aug 08 00:53:43 CST 2023, time=2023-08-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2142239, encodeId=d3b0214223935, content=偏重的研究方向：肿瘤临床;肝癌 经验分享：兄弟姐妹们咨询一下这个杂志选择传统订阅和OA 见刊的时间有什么区别啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Jun 11 18:35:54 CST 2023, time=2023-06-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2148975, encodeId=54d021489e5d8, content=快一个月了，还在审稿中，毕业需要，急死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201213/0c5ac7effe254ae4bce0fa2cc2887867/6649319072f04f49b9aaca73a211cec5.jpg, createdBy=9aac2516251, createdName=小懒emma, createdTime=Thu Jul 20 12:01:34 CST 2023, time=2023-07-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2151132, encodeId=0a4e215113204, content=请问这个杂志给了修改后辈=被拒的可能性大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=112d5638756, createdName=ms1000001834918815, createdTime=Thu Aug 03 17:18:20 CST 2023, time=2023-08-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2143995, encodeId=67b8214399524, content=投稿的大神吗，求求参考文献的格式呀？不知道什么名字呀，endnote里不知道该选谁, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c7a8160924, createdName=ms5000001590163843, createdTime=Tue Jun 20 23:46:57 CST 2023, time=2023-06-20, status=1, ipAttribution=辽宁省)]

2023-06-11 Doctor小雷来自重庆

偏重的研究方向：肿瘤临床;肝癌
经验分享：兄弟姐妹们咨询一下这个杂志选择传统订阅和OA 见刊的时间有什么区别啊

21 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2152407, encodeId=a94d215240ee6, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：请问大家可以看到分配的编辑吗，我这显示Submission under peer review21 Jul 2023，然后显示 5 Reviewer(s) invited 26 Jul 23。首页上又说再找编辑。We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks. 这是说我还没有编辑的意思吗，是不是没有编辑也没有人继续邀请审稿人啊，我能发邮件催吗，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b6c6396308, createdName=ms4000001131300035, createdTime=Sat Aug 12 10:52:29 CST 2023, time=2023-08-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151540, encodeId=f809215154037, content=请问大家，只有一个审稿人接收并提了意见，编辑会继续等第二个审稿人吗，时间也很长了，还是一个审稿人也可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/CCHXoTpZnFFfvva1H3xy1aeibn3UIslJAJQyZB1EA2ITXuG1sPcI48iaFvo5M8huD9dXqfLx0HUrExRmqm93YiaNQ/132, createdBy=a6f15243638, createdName=小伊森7290, createdTime=Sun Aug 06 22:51:12 CST 2023, time=2023-08-06, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2152409, encodeId=39a321524096f, content=这个期刊如果送外审后接收概率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221101/b9adfc4dea984dda8e0e6610a2452d0b/ac3111247cf04c10ab769ff52aeea3ca.jpg, createdBy=fb758187561, createdName=muei, createdTime=Sat Aug 12 10:53:14 CST 2023, time=2023-08-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151634, encodeId=24512151634d1, content=偏重的研究方向：肿瘤标志物;肝癌 经验分享：系统显示Peer review，怎么查看有几个审稿人呢，是不是还没审稿人愿意审稿？因为系统上还显示Your submission has passed the technical checks and is now in peer review We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Mon Aug 07 16:29:20 CST 2023, time=2023-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151745, encodeId=a6aa2151e45c6, content=APC费用：£2690.00/$4190.00/€3190.00, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcd85631555, createdName=医学空, createdTime=Tue Aug 08 10:53:37 CST 2023, time=2023-08-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2151711, encodeId=55fc2151e11b0, content=请问大家润色怎么处理的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Tue Aug 08 00:53:43 CST 2023, time=2023-08-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2142239, encodeId=d3b0214223935, content=偏重的研究方向：肿瘤临床;肝癌 经验分享：兄弟姐妹们咨询一下这个杂志选择传统订阅和OA 见刊的时间有什么区别啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Jun 11 18:35:54 CST 2023, time=2023-06-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2148975, encodeId=54d021489e5d8, content=快一个月了，还在审稿中，毕业需要，急死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201213/0c5ac7effe254ae4bce0fa2cc2887867/6649319072f04f49b9aaca73a211cec5.jpg, createdBy=9aac2516251, createdName=小懒emma, createdTime=Thu Jul 20 12:01:34 CST 2023, time=2023-07-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2151132, encodeId=0a4e215113204, content=请问这个杂志给了修改后辈=被拒的可能性大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=112d5638756, createdName=ms1000001834918815, createdTime=Thu Aug 03 17:18:20 CST 2023, time=2023-08-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2143995, encodeId=67b8214399524, content=投稿的大神吗，求求参考文献的格式呀？不知道什么名字呀，endnote里不知道该选谁, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c7a8160924, createdName=ms5000001590163843, createdTime=Tue Jun 20 23:46:57 CST 2023, time=2023-06-20, status=1, ipAttribution=辽宁省)]

2023-07-20 小懒emma 来自河南省

快一个月了，还在审稿中，毕业需要，急死了

27 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2152407, encodeId=a94d215240ee6, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：请问大家可以看到分配的编辑吗，我这显示Submission under peer review21 Jul 2023，然后显示 5 Reviewer(s) invited 26 Jul 23。首页上又说再找编辑。We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks. 这是说我还没有编辑的意思吗，是不是没有编辑也没有人继续邀请审稿人啊，我能发邮件催吗，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b6c6396308, createdName=ms4000001131300035, createdTime=Sat Aug 12 10:52:29 CST 2023, time=2023-08-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151540, encodeId=f809215154037, content=请问大家，只有一个审稿人接收并提了意见，编辑会继续等第二个审稿人吗，时间也很长了，还是一个审稿人也可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/CCHXoTpZnFFfvva1H3xy1aeibn3UIslJAJQyZB1EA2ITXuG1sPcI48iaFvo5M8huD9dXqfLx0HUrExRmqm93YiaNQ/132, createdBy=a6f15243638, createdName=小伊森7290, createdTime=Sun Aug 06 22:51:12 CST 2023, time=2023-08-06, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2152409, encodeId=39a321524096f, content=这个期刊如果送外审后接收概率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221101/b9adfc4dea984dda8e0e6610a2452d0b/ac3111247cf04c10ab769ff52aeea3ca.jpg, createdBy=fb758187561, createdName=muei, createdTime=Sat Aug 12 10:53:14 CST 2023, time=2023-08-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151634, encodeId=24512151634d1, content=偏重的研究方向：肿瘤标志物;肝癌 经验分享：系统显示Peer review，怎么查看有几个审稿人呢，是不是还没审稿人愿意审稿？因为系统上还显示Your submission has passed the technical checks and is now in peer review We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Mon Aug 07 16:29:20 CST 2023, time=2023-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151745, encodeId=a6aa2151e45c6, content=APC费用：£2690.00/$4190.00/€3190.00, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcd85631555, createdName=医学空, createdTime=Tue Aug 08 10:53:37 CST 2023, time=2023-08-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2151711, encodeId=55fc2151e11b0, content=请问大家润色怎么处理的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Tue Aug 08 00:53:43 CST 2023, time=2023-08-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2142239, encodeId=d3b0214223935, content=偏重的研究方向：肿瘤临床;肝癌 经验分享：兄弟姐妹们咨询一下这个杂志选择传统订阅和OA 见刊的时间有什么区别啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Jun 11 18:35:54 CST 2023, time=2023-06-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2148975, encodeId=54d021489e5d8, content=快一个月了，还在审稿中，毕业需要，急死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201213/0c5ac7effe254ae4bce0fa2cc2887867/6649319072f04f49b9aaca73a211cec5.jpg, createdBy=9aac2516251, createdName=小懒emma, createdTime=Thu Jul 20 12:01:34 CST 2023, time=2023-07-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2151132, encodeId=0a4e215113204, content=请问这个杂志给了修改后辈=被拒的可能性大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=112d5638756, createdName=ms1000001834918815, createdTime=Thu Aug 03 17:18:20 CST 2023, time=2023-08-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2143995, encodeId=67b8214399524, content=投稿的大神吗，求求参考文献的格式呀？不知道什么名字呀，endnote里不知道该选谁, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c7a8160924, createdName=ms5000001590163843, createdTime=Tue Jun 20 23:46:57 CST 2023, time=2023-06-20, status=1, ipAttribution=辽宁省)]

2023-08-03 ms1000001834918815 来自浙江省

请问这个杂志给了修改后辈=被拒的可能性大吗？

26 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2152407, encodeId=a94d215240ee6, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：请问大家可以看到分配的编辑吗，我这显示Submission under peer review21 Jul 2023，然后显示 5 Reviewer(s) invited 26 Jul 23。首页上又说再找编辑。We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks. 这是说我还没有编辑的意思吗，是不是没有编辑也没有人继续邀请审稿人啊，我能发邮件催吗，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b6c6396308, createdName=ms4000001131300035, createdTime=Sat Aug 12 10:52:29 CST 2023, time=2023-08-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151540, encodeId=f809215154037, content=请问大家，只有一个审稿人接收并提了意见，编辑会继续等第二个审稿人吗，时间也很长了，还是一个审稿人也可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/CCHXoTpZnFFfvva1H3xy1aeibn3UIslJAJQyZB1EA2ITXuG1sPcI48iaFvo5M8huD9dXqfLx0HUrExRmqm93YiaNQ/132, createdBy=a6f15243638, createdName=小伊森7290, createdTime=Sun Aug 06 22:51:12 CST 2023, time=2023-08-06, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2152409, encodeId=39a321524096f, content=这个期刊如果送外审后接收概率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221101/b9adfc4dea984dda8e0e6610a2452d0b/ac3111247cf04c10ab769ff52aeea3ca.jpg, createdBy=fb758187561, createdName=muei, createdTime=Sat Aug 12 10:53:14 CST 2023, time=2023-08-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151634, encodeId=24512151634d1, content=偏重的研究方向：肿瘤标志物;肝癌 经验分享：系统显示Peer review，怎么查看有几个审稿人呢，是不是还没审稿人愿意审稿？因为系统上还显示Your submission has passed the technical checks and is now in peer review We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Mon Aug 07 16:29:20 CST 2023, time=2023-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151745, encodeId=a6aa2151e45c6, content=APC费用：£2690.00/$4190.00/€3190.00, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcd85631555, createdName=医学空, createdTime=Tue Aug 08 10:53:37 CST 2023, time=2023-08-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2151711, encodeId=55fc2151e11b0, content=请问大家润色怎么处理的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Tue Aug 08 00:53:43 CST 2023, time=2023-08-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2142239, encodeId=d3b0214223935, content=偏重的研究方向：肿瘤临床;肝癌 经验分享：兄弟姐妹们咨询一下这个杂志选择传统订阅和OA 见刊的时间有什么区别啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Jun 11 18:35:54 CST 2023, time=2023-06-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2148975, encodeId=54d021489e5d8, content=快一个月了，还在审稿中，毕业需要，急死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201213/0c5ac7effe254ae4bce0fa2cc2887867/6649319072f04f49b9aaca73a211cec5.jpg, createdBy=9aac2516251, createdName=小懒emma, createdTime=Thu Jul 20 12:01:34 CST 2023, time=2023-07-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2151132, encodeId=0a4e215113204, content=请问这个杂志给了修改后辈=被拒的可能性大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=112d5638756, createdName=ms1000001834918815, createdTime=Thu Aug 03 17:18:20 CST 2023, time=2023-08-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2143995, encodeId=67b8214399524, content=投稿的大神吗，求求参考文献的格式呀？不知道什么名字呀，endnote里不知道该选谁, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c7a8160924, createdName=ms5000001590163843, createdTime=Tue Jun 20 23:46:57 CST 2023, time=2023-06-20, status=1, ipAttribution=辽宁省)]

2023-06-20 ms5000001590163843 来自辽宁省

投稿的大神吗，求求参考文献的格式呀？不知道什么名字呀，endnote里不知道该选谁

24 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务